Safety, Tolerability, Pharmacokinetics of hzVSf-v13 in Healthy Adults (Intravenous and Subcutaneous Administration)
Clinical trial NCT04817202 · COMPLETED
Trial details
- NCT number
- NCT04817202
- Sponsor
- ImmuneMed, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2022-01-15
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.